China, Cuba sign agreements to boost biotechnology cooperation
Africa
THE 12th meeting of the Cuba-China Joint Working Group of Biotech Cooperation ended on Thursday in the Cuban capital, Havana, with signing of agreements between the two countries.
The agreements included creating joint ventures, developing medicines for cancer treatment, creating a biopharmaceutical industrial park, and other topics of common interest.
Mr Wu Hao, China’s Secretary-General of the National Development and Reform Commission, said that the two countries would sign a memorandum of understanding soon to enhance biotechnology collaboration.
“China and Cuba complement each other in establishing a satisfactory base with huge potential for development,’’ he said.
He added that the two nations would continue to consolidate work results in years to come.
Mr Eduardo Martinez, President of Cuba’s biotech conglomerate, BioCubaFarma, said that the meeting identified important strategic work guidelines.
He said that he was confident that bilateral collaboration in the field would be enhanced.
The 12th meeting of the Cuba-China Joint Working Group of Biotech Cooperation started on Sept. 6 in Havana, with representatives from both countries. (Xinhua/NAN)
A.
-September. 07, 2023 @ 13:45 GMT |
Related Posts
Unlocking Africa’s Golden Potential: How digitisation can transform continent’s gold mines, combat illicit mining activities
AFRICA, the world’s top regional gold producer, is experiencing a modern-day gold rush driven by soaring gold prices and strategic...
Read MoreCSOs, stakeholders urge ECOWAS’ intervention for peaceful elections in Ghana
By Paul Ejime CIVIL Society Organisations (CSOs) and other major stakeholders have called for the intervention of the Economic Community...
Read MoreLagos NSCDC reiterates commitment to grassroot security
LAGOS State Command of the Nigeria Security and Civil Defence Corps (NSCDC), has reiterated its commitment to grassroot security. The...
Read MoreMost Read
Subscribe to Our Newsletter
Keep abreast of news and other developments from our website.